|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61P 35/00 |
| (11) | Number of the document | 3065770 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14803277.4 |
| Date of filing the European patent application | 2014-10-31 | |
| (97) | Date of publication of the European application | 2016-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/063516 |
| Date | 2014-10-31 |
| (87) | Number | WO 2015/069571 |
| Date | 2015-05-14 |
| (30) | Number | Date | Country code |
| 201361900226 P | 2013-11-05 | US |
| (72) |
ROUNTREE, Ryan, US
FOY, Susan, US
MANDL, Stefanie, US
DELCAYRE, Alain, US
|
| (73) |
Bavarian Nordic A/S,
Hejreskovvej 10A, 3490 Kvistgaard,
DK
|
| (54) | COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST OF AN IMMUNE CHECKPOINT INHIBITOR |
| COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST OF AN IMMUNE CHECKPOINT INHIBITOR |